NDC 70801-002 - Zilretta
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70801-002
- Package NDCs from labels
- 70801-002-01, 70801-002-02
- Manufacturer
- Flexion Therapeutics, Inc. | Packaging Coordinators, LLC (PCI) | Catalent Indiana, LLC | Synergy Health Sterilisation UK Ltd | Patheon UK Limited | Farmabios S.p.A. | Alcami Carolinas Corporation
- Effective date
- 2022-12-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| triamcinolone acetonide extended-release injectable suspension | Flexion Therapeutics, Inc. | Packaging Coordinators, LLC (PCI) | Catalent Indiana, LLC | Synergy Health Sterilisation UK Ltd | Patheon UK Limited | Farmabios S.p.A. | Alcami Carolinas Corporation | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sportpharm LLC | 4e0ddecf-7ea1-4f42-9924-53fe5a5657ff | 2026-02-10 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | ASCLEMED USA INC. | 1c6a740e-bc0d-41f3-b576-7d4c3880be23 | 2026-02-10 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | REMEDYREPACK INC. | c76d68dc-78e6-407c-ba9d-5d1c5d13509e | 2026-02-05 | Adverse reactions | F446C597KA |
| 0.9 percentsaline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 487cb4fc-2e0b-020f-e063-6294a90a4526 | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e76aca-ca2b-3b95-e063-6394a90a875e | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9%saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e7b329-e4e5-6991-e063-6294a90ac817 | 2026-02-03 | Warnings | 451W47IQ8X |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3 | 2026-01-30 | Warnings | 451W47IQ8X |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 451W47IQ8X |
| CVS ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | CVS | 44821c47-63f9-5d0a-e063-6394a90a555d | 2026-01-29 | Warnings | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | a5cc640f-c72d-49fa-b970-906c9ffd8629 | 2026-01-28 | Adverse reactions | F446C597KA |
| triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 92a1ded0-8e1a-4994-9c8a-89e84fc85c94 | 2026-01-28 | Adverse reactions | F446C597KA |
| Carboxymethylcellulose Sodium Eye Drops 0.5% | CARBOXYMETHYLCELLULOSE SODIUM EYE DROPS 0.5% | Aurolab | e8b4df3b-3d81-b3ca-e053-2a95a90af2ec | 2026-01-27 | Warnings | K679OBS311 |
| AURO-CMC | CARBOXYMETHYLCELLULOSE EYE DROPS 0.5% | Aurolab | e90b397f-fe64-8674-e053-2995a90a223f | 2026-01-27 | Warnings | K679OBS311 |
| Sodium Chloride | SODIUM CHLORIDE | Nephron Pharmaceuticals Corporation | a4edf2d5-a9ff-30d4-e053-2995a90a5650 | 2026-01-26 | Warnings, Adverse reactions | 451W47IQ8X |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | ASCLEMED USA INC. | b909659e-8dd5-4652-89f4-c4d6b741a855 | 2026-01-23 | Warnings, Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | NuCare Pharmaceuticals,Inc. | 5439cd3c-da8d-3b96-e054-00144ff8d46c | 2026-01-21 | Adverse reactions | F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | REMEDYREPACK INC. | 037efc03-22ab-45eb-9b0e-b125e4b5eb99 | 2026-01-20 | Adverse reactions | F446C597KA |
| Sodium Chloride | SODIUM CHLORIDE | ProPharma Distribution | 48d73434-e65b-dc98-e063-6294a90affa2 | 2026-01-20 | Adverse reactions | 451W47IQ8X |
| Equate Comfort Flow Sinus wash | SINUS WASH | WALMART INC | 9e911eef-ca99-9902-e053-2a95a90aab0e | 2026-01-19 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.